Skip to main content
Top
Published in: BMC Infectious Diseases 1/2020

Open Access 01-12-2020 | Ebola Virus | Research article

A retrospective cohort investigation of seroprevalence of Marburg virus and ebolaviruses in two different ecological zones in Uganda

Authors: Luke Nyakarahuka, Ilana J. Schafer, Stephen Balinandi, Sophia Mulei, Alex Tumusiime, Jackson Kyondo, Barbara Knust, Julius Lutwama, Pierre Rollin, Stuart Nichol, Trevor Shoemaker

Published in: BMC Infectious Diseases | Issue 1/2020

Login to get access

Abstract

Background

Uganda has experienced seven Ebola Virus Disease (EVD) outbreaks and four Marburg Virus Disease (MVD) outbreaks between 2000 and 2019. We investigated the seroprevalence and risk factors for Marburg virus and ebolaviruses in gold mining communities around Kitaka gold mine in Western Uganda and compared them to non-mining communities in Central Uganda.

Methods

A questionnaire was administered and human blood samples were collected from three exposure groups in Western Uganda (gold miners, household members of miners, non-miners living within 50 km of Kitaka mine). The unexposed controls group sampled was community members in Central Uganda far away from any gold mining activity which we considered as low-risk for filovirus infection. ELISA serology was used to analyse samples, detecting IgG antibodies against Marburg virus and ebolaviruses (filoviruses). Data were analysed in STATA software using risk ratios and odds ratios.

Results

Miners in western Uganda were 5.4 times more likely to be filovirus seropositive compared to the control group in central Uganda (RR = 5.4; 95% CI 1.5–19.7) whereas people living in high-risk areas in Ibanda and Kamwenge districts were 3.6 more likely to be seropositive compared to control group in Luweeero district (RR = 3.6; 95% CI 1.1–12.2). Among all participants, filovirus seropositivity was 2.6% (19/724) of which 2.3% (17/724) were reactive to Sudan virus only and 0.1% (1/724) to Marburg virus. One individual seropositive for Sudan virus also had IgG antibodies reactive to Bundibugyo virus. The risk factors for filovirus seropositivity identified included mining (AOR = 3.4; 95% CI 1.3–8.5), male sex (AOR = 3.1; 95% CI 1.01–9.5), going inside mines (AOR = 3.1; 95% CI 1.2–8.2), cleaning corpses (AOR = 3.1; 95% CI 1.04–9.1) and contact with suspect filovirus cases (AOR = 3.9, 95% CI 1.04–14.5).

Conclusions

These findings indicate that filovirus outbreaks may go undetected in Uganda and people involved in artisan gold mining are more likely to be exposed to infection with either Marburg virus or ebolaviruses, likely due to increased risk of exposure to bats. This calls for active surveillance in known high-risk areas for early detection and response to prevent filovirus epidemics.
Literature
1.
go back to reference Nyakarahuka L, Kankya C, Krontveit R, Mayer B, Mwiine FNFN, Lutwama J, et al. How severe and prevalent are Ebola and Marburg viruses? A systematic review and meta-analysis of the case fatality rates and seroprevalence. BMC Infect Dis. 2016;16:708. https://doi.org/10.1186/s12879-016-2045-6. Nyakarahuka L, Kankya C, Krontveit R, Mayer B, Mwiine FNFN, Lutwama J, et al. How severe and prevalent are Ebola and Marburg viruses? A systematic review and meta-analysis of the case fatality rates and seroprevalence. BMC Infect Dis. 2016;16:708. https://​doi.​org/​10.​1186/​s12879-016-2045-6.
3.
5.
7.
go back to reference Bennett S, Woods T, Liyanage WM, Smith DL. A simplified general method for cluster-sample surveys of health in developing countries. World Health Statistics Quarterly. 1991;44(3):98–106. Bennett S, Woods T, Liyanage WM, Smith DL. A simplified general method for cluster-sample surveys of health in developing countries. World Health Statistics Quarterly. 1991;44(3):98–106.
9.
go back to reference Ksiazek TG, West CP, Rollin PE, Jahrling PB, Peters CJ. ELISA for the detection of antibodies to Ebola viruses. J Infect Dis. 1999;179(Suppl):S192–8.CrossRef Ksiazek TG, West CP, Rollin PE, Jahrling PB, Peters CJ. ELISA for the detection of antibodies to Ebola viruses. J Infect Dis. 1999;179(Suppl):S192–8.CrossRef
10.
go back to reference Knust B, Schafer IJ, Wamala J, Nyakarahuka L, Okot C, Shoemaker T, Dodd K, Gibbons A, Balinandi S, Tumusiime A, Campbell S, Newman E, Lasry E, DeClerck H, Boum Y, Makumbi I, Bosa HK, Mbonye A, Aceng JR, Nichol ST, Rollin PE. Multidistrict Outbreak of Marburg Virus Disease-Uganda, 2012. J Infect Dis. 2015;212 Suppl 2(Suppl 2):S119–S128. https://doi.org/10.1093/infdis/jiv351. Knust B, Schafer IJ, Wamala J, Nyakarahuka L, Okot C, Shoemaker T, Dodd K, Gibbons A, Balinandi S, Tumusiime A, Campbell S, Newman E, Lasry E, DeClerck H, Boum Y, Makumbi I, Bosa HK, Mbonye A, Aceng JR, Nichol ST, Rollin PE. Multidistrict Outbreak of Marburg Virus Disease-Uganda, 2012. J Infect Dis. 2015;212 Suppl 2(Suppl 2):S119–S128. https://​doi.​org/​10.​1093/​infdis/​jiv351.
12.
go back to reference Becker S, Feldmann H, Will C, Slenczka W. Evidence for occurrence of filovirus antibodies in humans and imported monkeys: do subclinical filovirus infections occur worldwide? Med Microbiol Immunol. 1992;181:43–55.CrossRef Becker S, Feldmann H, Will C, Slenczka W. Evidence for occurrence of filovirus antibodies in humans and imported monkeys: do subclinical filovirus infections occur worldwide? Med Microbiol Immunol. 1992;181:43–55.CrossRef
13.
go back to reference Johnson BK, Ocheng D, Gichogo A, Okiro M, Libondo D, Tukei PM, et al. Antibodies against haemorrhagic fever viruses in Kenya populations. Trans R Soc Trop Med Hyg. 1983;77:731–3.CrossRef Johnson BK, Ocheng D, Gichogo A, Okiro M, Libondo D, Tukei PM, et al. Antibodies against haemorrhagic fever viruses in Kenya populations. Trans R Soc Trop Med Hyg. 1983;77:731–3.CrossRef
14.
go back to reference van der Waals FW, Pomeroy KL, Goudsmit J, Asher DM, Gajdusek DC. Hemorrhagic fever virus infections in an isolated rainforest area of Central Liberia. Limitations of the indirect immunofluorescence slide test for antibody screening in Africa. Trop Geogr Med. 1986;38:209–14.PubMed van der Waals FW, Pomeroy KL, Goudsmit J, Asher DM, Gajdusek DC. Hemorrhagic fever virus infections in an isolated rainforest area of Central Liberia. Limitations of the indirect immunofluorescence slide test for antibody screening in Africa. Trop Geogr Med. 1986;38:209–14.PubMed
16.
go back to reference Johnson ED, Gonzalez JP, Georges A. Filovirus activity among selected ethnic-groups inhabiting the tropical Forest of equatorial Africa. Trans R Soc Trop Med Hyg. 1993;87:536–8.CrossRef Johnson ED, Gonzalez JP, Georges A. Filovirus activity among selected ethnic-groups inhabiting the tropical Forest of equatorial Africa. Trans R Soc Trop Med Hyg. 1993;87:536–8.CrossRef
19.
go back to reference Nkoghe D, Padilla C, Becquart P, Wauquier N, Moussavou G, Akué JP, et al. Risk factors for zaire ebolavirus-specific IgG in rural gabonese populations. J Infect Dis. 2011;204 SUPPL. 3. Nkoghe D, Padilla C, Becquart P, Wauquier N, Moussavou G, Akué JP, et al. Risk factors for zaire ebolavirus-specific IgG in rural gabonese populations. J Infect Dis. 2011;204 SUPPL. 3.
22.
go back to reference Tomori O, Fabiyi A, Sorungbe A, Smith A, McCormick JB. Viral hemorrhagic fever antibodies in Nigerian populations. Am J Trop Med Hyg. 1988;38:407–10.CrossRef Tomori O, Fabiyi A, Sorungbe A, Smith A, McCormick JB. Viral hemorrhagic fever antibodies in Nigerian populations. Am J Trop Med Hyg. 1988;38:407–10.CrossRef
23.
go back to reference Brainard J, Hooper L, Pond K, Edmunds K, Hunter PR. Risk factors for transmission of Ebola or Marburg virus disease: a systematic review and meta-analysis. Int J Epidemiol. 2016;45:102–16.CrossRef Brainard J, Hooper L, Pond K, Edmunds K, Hunter PR. Risk factors for transmission of Ebola or Marburg virus disease: a systematic review and meta-analysis. Int J Epidemiol. 2016;45:102–16.CrossRef
26.
go back to reference Glynn JR, Bower H, Johnson S, Houlihan CF, Montesano C, Scott JT, et al. Asymptomatic infection and unrecognised Ebola virus disease in Ebola-affected households in Sierra Leone: a cross-sectional study using a new non-invasive assay for antibodies to Ebola virus. Lancet Infect Dis. 2017;17(6):645–53. https://doi.org/10.1016/S1473-3099(17)30111-1. Glynn JR, Bower H, Johnson S, Houlihan CF, Montesano C, Scott JT, et al. Asymptomatic infection and unrecognised Ebola virus disease in Ebola-affected households in Sierra Leone: a cross-sectional study using a new non-invasive assay for antibodies to Ebola virus. Lancet Infect Dis. 2017;17(6):645–53. https://​doi.​org/​10.​1016/​S1473-3099(17)30111-1.
27.
go back to reference Busico KM, Marshall KL, Ksiazek TG, Roels TH, Fleerackers Y, Feldmann H, et al. Prevalence of IgG antibodies to Ebola virus in individuals during an Ebola outbreak, Democratic Republic of the Congo, 1995. J Infect Dis. 1999;179(Suppl):S102–7.CrossRef Busico KM, Marshall KL, Ksiazek TG, Roels TH, Fleerackers Y, Feldmann H, et al. Prevalence of IgG antibodies to Ebola virus in individuals during an Ebola outbreak, Democratic Republic of the Congo, 1995. J Infect Dis. 1999;179(Suppl):S102–7.CrossRef
29.
go back to reference Heymann DL, Weisfeld JS, Webb PA, Johnson KM, Cairns T, Berquist H. Ebola hemorrhagic fever: Tandala, Zaire, 1977-1978. J Infect Dis. 1980;142:372–6.CrossRef Heymann DL, Weisfeld JS, Webb PA, Johnson KM, Cairns T, Berquist H. Ebola hemorrhagic fever: Tandala, Zaire, 1977-1978. J Infect Dis. 1980;142:372–6.CrossRef
30.
go back to reference Van Der Groen G, Pattyn SR. Measurement of antibodies to Ebola virus in human sera from N.W.-Zaire. Ann Soc Belg Med Trop (1920). 1979;59(1):87–92. Van Der Groen G, Pattyn SR. Measurement of antibodies to Ebola virus in human sera from N.W.-Zaire. Ann Soc Belg Med Trop (1920). 1979;59(1):87–92.
31.
go back to reference Allela L, Bourry O, Pouillot R, Délicat A, Yaba P, Kumulungui B, et al. Ebola virus antibody prevalence in dogs and human risk. Emerg Infect Dis. 2005;11:385–90.CrossRef Allela L, Bourry O, Pouillot R, Délicat A, Yaba P, Kumulungui B, et al. Ebola virus antibody prevalence in dogs and human risk. Emerg Infect Dis. 2005;11:385–90.CrossRef
32.
go back to reference Heffernan RT, Pambo B, Hatchett RJ, Leman PA, Swanepoel R, Ryder RW. Low seroprevalence of IgG antibodies to Ebola virus in an epidemic zone: Ogooué-Ivindo region, northeastern Gabon, 1997. J Infect Dis. 2005;191:964–8.CrossRef Heffernan RT, Pambo B, Hatchett RJ, Leman PA, Swanepoel R, Ryder RW. Low seroprevalence of IgG antibodies to Ebola virus in an epidemic zone: Ogooué-Ivindo region, northeastern Gabon, 1997. J Infect Dis. 2005;191:964–8.CrossRef
33.
go back to reference Lahm SA, Kombila M, Swanepoel R, Barnes RFWW. Morbidity and mortality of wild animals in relation to outbreaks of Ebola haemorrhagic fever in Gabon, 1994-2003. Trans R Soc Trop Med Hyg. 2007;101:64–78.CrossRef Lahm SA, Kombila M, Swanepoel R, Barnes RFWW. Morbidity and mortality of wild animals in relation to outbreaks of Ebola haemorrhagic fever in Gabon, 1994-2003. Trans R Soc Trop Med Hyg. 2007;101:64–78.CrossRef
34.
go back to reference Georges AJ, Leroy EM, Renaut AA, Benissan CT, Nabias RJ, Ngoc MT, et al. Ebola hemorrhagic fever outbreaks in Gabon, 1994-1997: epidemiologic and health control issues. J Infect Dis. 1999;179(Suppl):S65–75.CrossRef Georges AJ, Leroy EM, Renaut AA, Benissan CT, Nabias RJ, Ngoc MT, et al. Ebola hemorrhagic fever outbreaks in Gabon, 1994-1997: epidemiologic and health control issues. J Infect Dis. 1999;179(Suppl):S65–75.CrossRef
35.
go back to reference Bertherat E, Renaut A, Nabias R, Dubreuil G, Georges-Courbot MC. Leptospirosis and Ebola virus infection in five gold-panning villages in northeastern Gabon. Am J Trop Med Hyg. 1999;60:610–5.CrossRef Bertherat E, Renaut A, Nabias R, Dubreuil G, Georges-Courbot MC. Leptospirosis and Ebola virus infection in five gold-panning villages in northeastern Gabon. Am J Trop Med Hyg. 1999;60:610–5.CrossRef
36.
go back to reference Baron RC, McCormick JB, Zubeir OA. Ebola virus disease in southern Sudan: hospital dissemination and intrafamilial spread. Bull World Health Organ. 1983;61:997–1003.PubMedPubMedCentral Baron RC, McCormick JB, Zubeir OA. Ebola virus disease in southern Sudan: hospital dissemination and intrafamilial spread. Bull World Health Organ. 1983;61:997–1003.PubMedPubMedCentral
37.
go back to reference Meunier DM, Johnson ED, Gonzalez JP, Georges-Courbot MC, Madelon MC, Georges AJ. Current serologic data on viral hemorrhagic fevers in the Central African Republic. Bull Soc Pathol Exot Filiales. 1987;80:51–61.PubMed Meunier DM, Johnson ED, Gonzalez JP, Georges-Courbot MC, Madelon MC, Georges AJ. Current serologic data on viral hemorrhagic fevers in the Central African Republic. Bull Soc Pathol Exot Filiales. 1987;80:51–61.PubMed
39.
go back to reference Paix MA, Poveda JD, Malvy D, Bailly C, Merlin M, Fleury HJ. Serological study of the virus responsible for hemorrhagic fever in an urban population of Cameroon. Bull Soc Pathol Exot Filiales. 1988;81:679–82.PubMed Paix MA, Poveda JD, Malvy D, Bailly C, Merlin M, Fleury HJ. Serological study of the virus responsible for hemorrhagic fever in an urban population of Cameroon. Bull Soc Pathol Exot Filiales. 1988;81:679–82.PubMed
41.
go back to reference Natesan M, Jensen SM, Keasey SL, Kamata T, Kuehne AI, Stonier SW, et al. Human survivors of disease outbreaks caused by Ebola or Marburg virus exhibit cross-reactive and long-lived antibody responses. Clin Vaccine Immunol. 2016;23(8):717–24. https://doi.org/10.1128/CVI.00107-16. Natesan M, Jensen SM, Keasey SL, Kamata T, Kuehne AI, Stonier SW, et al. Human survivors of disease outbreaks caused by Ebola or Marburg virus exhibit cross-reactive and long-lived antibody responses. Clin Vaccine Immunol. 2016;23(8):717–24. https://​doi.​org/​10.​1128/​CVI.​00107-16.
Metadata
Title
A retrospective cohort investigation of seroprevalence of Marburg virus and ebolaviruses in two different ecological zones in Uganda
Authors
Luke Nyakarahuka
Ilana J. Schafer
Stephen Balinandi
Sophia Mulei
Alex Tumusiime
Jackson Kyondo
Barbara Knust
Julius Lutwama
Pierre Rollin
Stuart Nichol
Trevor Shoemaker
Publication date
01-12-2020
Publisher
BioMed Central
Keyword
Ebola Virus
Published in
BMC Infectious Diseases / Issue 1/2020
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-020-05187-0

Other articles of this Issue 1/2020

BMC Infectious Diseases 1/2020 Go to the issue